Prostate cancer Board decisions

The Board granted the restoration of a 60 percent evaluation effective September 23, 2021 for service-connected prostate cancer residuals.

The Board granted service connection for prostate cancer, resolving reasonable doubt in the Veteran's favor.

The Board granted service connection for migraine headaches as secondary to the Veteran's service-connected tinnitus, resolving reasonable doubt in favor of the Veteran. The claim for prostate cancer was remanded for further development.

The Board denied service connection for a left hand disability, left wrist disability, and residuals of prostate cancer as the evidence did not support a finding that these conditions were related to the Veteran's period of active service.

The Board remands the Veteran's claim for service connection for prostate cancer to obtain an addendum opinion addressing his exposure to ionizing radiation.

The Board granted service connection for prostate cancer, finding that the Veteran was exposed to herbicide agents while serving near the Korean demilitarized zone at Fort Casey.

The Board denied service connection for diabetes mellitus type II, prostate cancer, and peripheral neuropathy in the right and left upper and lower extremities as there was no evidence of an in-service injury or disease related to these conditions.

The Board denied the Veteran's claim for a total disability rating based on individual unemployability due to his service-connected prostate cancer and erectile dysfunction, as these conditions do not prevent him from securing or following substantially gainful employment.

The Board denied initial compensable ratings for squamous cell carcinoma and prostate cancer, finding that the Veteran's conditions did not meet the criteria for a compensable rating.

The Board denied service connection for a right ankle disability, left ankle disability, and prostate cancer as the evidence did not support a finding of current disabilities or a link to in-service injuries or exposures.

The Board granted service connection for prostate cancer, a radiogenic disease, due to the Veteran's exposure to ionizing radiation during active-duty service.

The Veteran's service connection for right ankle pain was granted, while his claims for ED and prostate cancer were denied.

The Board remands the claims for an earlier effective date for service connection and a higher initial rating due to inadequate medical opinions.

The Board denied service connection for prostate cancer and metastatic cancer to the bone, finding no evidence of in-service exposure to herbicides or a direct link between the cancers and the Veteran's military service.

The Board remands the claims for service connection for diabetes mellitus type II, hypertension, bilateral upper extremity neuropathy, bilateral lower extremity neuropathy, and prostate cancer due to duty to assist errors.

The Board remands the claims for service connection due to a pre-decisional duty to assist error, as the November 2023 TERA opinions are inadequate.

The Board granted service connection for prostate cancer and denied service connection for fatty liver disease. The issues related to pelvic metastasis with hip pain and chronic back pain were remanded.

The Veteran's service-connected PTSD was granted a rating of 70 percent, but no greater, for the period on appeal prior to December 31, 2020. The claim for an increased rating in excess of 60 percent for residuals of prostate cancer was denied.

The Board granted service connection for prostate cancer, finding a link to the Veteran's in-service exposure to contaminated water at Camp Lejeune.

The Board remands the claim for service connection for prostate cancer to obtain an adequate medical opinion on its etiology, particularly in light of new evidence of conceded toxic chemical exposures.